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Abstract
Protein glycation is a non-enzymatic reaction between reducing sugars and amino groups that occurs in vivo and has been implicated
in a number of disease states and pathologies including Alzheimer’s and diabetes. Although glycation is thought to alter protein structure
and function, there is currently little information on the structural consequences of this modiﬁcation. We have used a model a-helix and a
model b-hairpin peptide, and NMR analysis, to investigate the eﬀects of glycation upon secondary structure. Glycation of the dilysine
motif within the a-helix peptide occurred preferentially at one lysine residue and resulted in severe disruption to the local secondary
structure. The area immediately around the site of modiﬁcation was extremely ﬂexible and the peptide did not adopt a preferred con-
formation in this area of the helix in 30% TFE. Signiﬁcant glycation of the b-hairpin peptide was not detected and the structure was
unchanged. These results show that glycation results in local secondary structure distortion of a-helices and that preferential glycation
occurs in a sequence speciﬁc manner. The ﬁndings will allow us to interrogate the local environment in other peptides/proteins to predict
the likelihood of glycation, and to model the potential eﬀects such modiﬁcation might have upon structure/function.
 2007 Elsevier Inc. All rights reserved.
Keywords: NMR; Glycation; Peptide secondary structure; a-Helix; b-Turn
1. Introduction
Non-enzymatic glycation of proteins has been shown to
be a potential problem during their storage in the food and
biotech industries (Davis et al., 2001; Smales et al., 2002),
and also in human health as a complication of diseases
such as diabetes (Al-Abed et al., 1999; Stitt, 2001). Glyca-
tion occurs via the Maillard reaction in which a reducing
sugar reacts with an amino group on a protein, either at
the NH2 terminus or at the e-amino group of lysine resi-
dues (Tagami et al., 2000; Yeboah et al., 2004). This results
in the formation of Amadori products for reaction with
glucose (Bucala, 1996) or Heyns products for reaction with
fructose (Suarez et al., 1989). These adducts can then fur-
ther react and rearrange to give a spectrum of products
known as Advanced Glycation End products or AGEs
(Cohen, 2003).
Many foodstuﬀs and biotech products are necessarily
processed and stored in the presence of sugars to aid in
maintaining protein integrity (Smales et al., 2000). Non-
enzymatic glycation and subsequent AGE formation of
such products may aﬀect protein structure, function and
immunogenicity (Howard and Smales, 2005). Although
these reactions and the eﬀects of these modiﬁcations on
protein function have been studied for several decades, pre-
diction of where modiﬁcation may take place, or of the
eﬀect on protein structure, remains largely unknown. A
better understanding of those residues, protein sequences
or structures that are prone to modiﬁcation, and the eﬀect
of this modiﬁcation on structure and ultimately function,
will allow the development of approaches to protect
against or limit these potentially harmful modiﬁcations.
Despite all the interest in non-enzymatic glycation, until
recently very little was known about the detailed structural
changes that occur within either the modiﬁed protein or at
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the secondary structure level. Certainly, it has been
reported that glycation and subsequent AGE formation
can give rise to protein aggregation, interaction with other
proteins and lead to the inactivation of enzymes (Yeboah
et al., 2004). More recently we used NMR and a model
helical peptide from human serum albumin (HSA) to show
that glycation with glucose caused the helical nature of the
peptide to be distorted around the region of the site of
modiﬁcation (Howard and Smales, 2005). This study also
showed that preferential glycation of one lysine residue
within a dilysine motif occurred, in agreement with previ-
ous studies that have shown this to be the case in the intact
protein (Iberg and Flu¨ckiger, 1986). This preferential gly-
cation appears to be the result of the surrounding environ-
ment that leaves one lysine amino group more nucleophilic
than its neighbor. In one of the few other studies that have
looked at protein glycation in a structural context, Mendez
et al. (2005) investigated how non-enzymatic glycation
aﬀected the secondary and tertiary structures of intact
HSA (Mendez et al., 2005). Using CD and ﬂuorescence-
based methods they showed that there was some perturba-
tion of local structure following glycation but that the over-
all structure of the protein remained unchanged, although
these methods have relatively low structural resolution.
Here, we have extended our previous NMR based study
(Howard and Smales, 2005) to determine if perturbation in
local secondary structure upon glycation is conserved
across diﬀerent helical peptides and in other secondary
structures. Speciﬁcally, we have investigated the eﬀect of
non-enzymatic glycation on a helical peptide from hen
egg white lysozyme (helix 4) that has previously been
shown to be glycated (Tagami et al., 2000). The peptide
also contains a dilysine motif and in the intact protein
one of these lysine’s is preferentially glycated (Smales
et al., 2000). We also investigated a second model peptide
forming a diﬀerent secondary structure corresponding to
the AB turn region of tissue inhibitor of metalloprotein-
ases-2 (TIMP-2) (Muskett et al., 1998). This peptide con-
tains only a single lysine residue allowing us to
investigate whether a single lysine is as susceptible to glyca-
tion and further, whether glycation resulted in secondary
structure distortion in a similar manner to that observed
in helical peptides.
Using the lysozyme model peptide and NMR analysis in
the presence of 30% triﬂuoroethanol (TFE) we have shown
that the unmodiﬁed peptide forms a helix similar to that
in the intact protein but that upon glycation the structure
of this helix is considerably disrupted in the region of the
modiﬁcation. One lysine was preferentially glycated over
the other in agreement with the data for intact lysozyme
(Smales et al., 2000). Signiﬁcant glycation of the TIMP-2
AB b-hairpin peptide was not detected, although this pep-
tide contains only a single lysine residue. The structure of
the peptide before and after the glycation reaction was
identical and representative of the equivalent region in
the intact TIMP-2 protein. Collectively our results show
that glycation results in local secondary structure distor-
tion of a-helices and that preferential glycation occurs in
a sequence speciﬁc manner. The results of this investigation
will allow investigators to predict the likely sites of protein
glycation in intact proteins and model the possible eﬀect on
local secondary structure. Such knowledge will help aid the
development of novel strategies to limit or eliminate these
potentially damaging reactions. As such we discuss our
results in terms of both the structure/function conse-
quences and bioprocessing of therapeutic or food-based
proteins.
2. Materials and methods
All materials were of analytical reagent grade or better
and purchased from Sigma Aldrich unless otherwise stated.
2.1. Synthesis and puriﬁcation of the peptides corresponding
to hen egg white lysozyme helix 4 and tissue inhibitor of
metalloproteinases-2 (TIMP-2) b-hairpin between strands A
and B
The peptides SDPTASVNCAKKIVSDGNGM (lyso-
zyme helix 4) and CVDSGNDIYGNPIKRC (TIMP-2 b-
hairpin between strands A and B) were synthesized using
a Shimadzu PSSM-8 Multiple Peptide Synthesizer and an
fmoc/HBTu synthesis strategy. The termini of peptides
were in an unprotected state for all experiments. The
TIMP-2 AB b-hairpin peptide was oxidized for 6 days in
ammonium bicarbonate buﬀer to ensure that disulphide
bond formation was complete. The resulting peptides were
puriﬁed by reverse-phase HPLC using a preparative C18
10 · 250 mm column linked to a Waters series HPLC
machine. The peptides were injected onto the column and
salts washed out with 10% acetonitrile containing 0.05%
TFA. The peptides were then eluted from the column using
a linear gradient from 10 to 70% acetonitrile (containing
0.045% TFA) over 45 min. The peptide peaks were col-
lected and freeze-dried overnight. Multiple runs were com-
bined in order to purify each of the synthesized peptides.
The authenticities of the puriﬁed peptides were conﬁrmed
by electrospray mass spectrometry. Mass spectra were
recorded in the positive ion mode using the extended mass
range (m/z 250–4000) on a Finnigan MAT LCQ ion-trap
mass spectrometer.
2.2. Glycation of the synthetic lysozyme and TIMP-2
peptides
Glycated peptide was generated using the conditions
and procedures previously described (Howard and Smales,
2005).
2.3. NMR sample preparation
For NMR analysis peptide samples were prepared as
previously described (Povey et al., 2007), except in the case
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of the TIMP-2 AB b-hairpin peptide whereby TFE was
omitted from the sample.
2.4. NMR spectroscopy
All experiments were recorded on a Varian UnityINO-
VA 600 MHz NMR spectrometer with a z-shielded gradi-
ent triple resonance probe using standard procedures,
essentially as previously described (Howard and Smales,
2005). The lysozyme peptide experiments were recorded
at 10 C and the TIMP-2 AB b-hairpin peptide experiments
were run and recorded at 0 C. For each peptide sample, a
two-dimensional nuclear Overhauser eﬀect spectroscopy
(NOESY) and total correlation spectroscopy (TOCSY)
experiment was recorded with mixing times of 250 and
80 ms, respectively. These experiments were collected with
512 and 2048 complex points with acquisition times of 79
and 315 ms in the indirectly and directly acquired 1H
dimensions, respectively. Data processing and analysis
were carried out on using NMRPipe (Delaglio et al.,
1995) and NMRView (Johnson and Blevins, 1994), respec-
tively. All chemical shifts were referenced externally to a
100 lM solution of dimethylsilapetane sulphonic acid
(DSS) in PBS containing 30% (v/v) TFE for lysozyme helix
four experiments and to a 100 lM solution of dimethylsil-
apetane sulphonic acid (DSS) in PBS for the TIMP-2 AB
hairpin experiments.
2.5. Structural calculations and analysis
All structural calculations were undertaken using the
Crystallography and NMR System (CNS) version 1.1
(Brunger et al., 1998) running on Silicon Graphics O2+
and Transtec X2100 Linux workstations. CNS parameter
ﬁles were modiﬁed to incorporate the covalent structure
of the modiﬁed lysine residue for calculations. All NOE
contacts were grouped into one wide classiﬁcation between
1.8 and 5.0 A˚ with ﬁnal structures calculated from
extended coordinates using the standard CNS NMR
anneal protocol with sum averaging for dynamic annealing
with NOEs from both extended and folded precursors
(Brunger et al., 1998). We chose not to classify the NOEs
into diﬀerent classes in order to be careful not to give
any one NOE more inﬂuence over another. H-bond donor
receptor pairs and secondary structure / restrains were
deduced from the initial structural calculations and then
subsequently used during the reﬁnement of the ﬁnal ensem-
bles. Final structural ensembles of 40 structures for each
lysozyme helix 4, and 30 structures for each TIMP-2 AB
b-hairpin peptide, were produced with all structures used
to produce statistical energy and root mean square (rms)
deviation structural information. Backbone and heavy
atom rms deviation values were obtained using MOLMOL
version 2k.2 (Koradi et al., 1996). The structural integrity
of each ensemble was evaluated using PROCHECK-
NMR (Laskowski et al., 1996). The comparison of the
energies between the calculated structures determined in
this work and the equivalent helix from lysozyme and turn
from TIMP-2 were undertaken using GROMOS96 43B1
parameter set (van Gunsteren et al., 1994) within DEEP-
VIEW version 3.7 (Guex and Peitsch, 1997).
3. Results
3.1. Peptide synthesis, glycation and puriﬁcation
The peptide sequences corresponding to lysozyme a-
helix 4 (residues 86–105) and TIMP-2 AB b-hairpin (resi-
dues 29–42) were successfully synthesized on a Shimadzu
PSSM-8 Multiple Peptide Synthesizer as determined by
mass spectrometry. The peptide sequence of the helix was
identical to that found in the native lysozyme molecule
except that the third residue Ile88 was deliberately replaced
with a proline residue (calculated mass = 1993.0 Da, exper-
imental mass = 1993.9 Da). The peptide sequence for the
TIMP-2 AB b-hairpin was identical to that found in the
native TIMP-2 molecule except for the addition of a cys-
teine residue at each end of the peptide. These cysteine res-
idues were oxidized to form a disulphide bridge, formation
of which was once again conﬁrmed by mass spectrometry
(calculated mass = 1750.8 Da, experimental mass =
1751.7 Da).
3.2. NMR resonance assignments
Spin systems were identiﬁed by analysis of two-dimen-
sional TOCSY NMR spectra and all the observed 1H
chemical shifts are listed in Tables 1 and 2 for the lysozyme
helix and TIMP-2 AB b-hairpin peptides, respectively.
Almost all 1H spin systems were assigned for the unmodi-
ﬁed and modiﬁed peptide for lysozyme helix 4 and TIMP-2
AB b-hairpin as described in Tables 1 and 2.
The TOCSY NMR spectra of the lysozyme helix 4 pep-
tide after glycation contained a deﬁned ‘sugar box’ region
corresponding to peaks derived from the attached sugar
residue which, as expected, was absent from the control
unmodiﬁed peptide (Fig. 1A v Fig. 1B). As this peptide
contains two lysine residues, it was necessary to determine
whether one of these residues was preferentially glycated or
if there was a mixed population of monoglycated peptides
and diglycated material present. Determination and assign-
ment of the glycated lysine residue in lysozyme helix 4 was
undertaken by direct comparison of the changes in the
spectra before and after modiﬁcation. Both Lys96 and
Lys97 were unambiguously identiﬁed using NOE data in
the spectra of the unmodiﬁed peptide. Following modiﬁca-
tion there was a marked change in the Ha chemical shift for
Lys97 but not Lys96 (see Table 1 and Fig. 2A). Interestingly,
while the Ha chemical shift of Lys96 showed no change in
the glycated form the other residues directly adjacent to
the two Lys residues (Cys94 and Ile98) showed a large
change in the chemical shift in the modiﬁed form (Table
1 and Fig. 2A). Investigation of the chemical shifts for each
of the protons within the two lysine residues once again
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showed that in the modiﬁed peptide Lys96 chemical shifts
were unchanged from the native whilst those of Lys97
showed large changes (Fig. 3). This was also conﬁrmed
by CSI analysis of the chemical shift data (data not shown).
The TOCSY NMR spectra of the TIMP-2 AB b-hairpin
after glycation did contain a weak and less well deﬁned
‘sugar box’ compared to the control unmodiﬁed peptide
(Fig. 1C v Fig. 1D), suggesting that limited glycation had
occurred. This peptide contains only one lysine residue
(Lys41), which was unambiguously identiﬁed using NOE
data in the spectra of the unmodiﬁed peptide. Following
subjection of the peptide to conditions that should result
in modiﬁcation there was no observable change in the Ha
chemical shifts of Lys41 and the H shifts for the rest of
the sidechain remained more-or-less unchanged between
the modiﬁed and unmodiﬁed peptide (see Table 2). Fur-
ther, there was relatively little change in the Ha chemical
shifts throughout the entire TIMP-2 AB b-hairpin peptide
following glycation (Table 2 and Fig. 2B), suggesting that
glycation had occurred on only a very small proportion
of the peptide molecules, or alternatively, that glycation
had no eﬀect on the structure under the conditions that
the data was collected.
3.3. Structural assignments and additional restraints
Through-space assignments were achieved using two-
dimensional NOESY spectra of the unmodiﬁed and glycat-
Table 1
Helix 4 NMR assignment list of observed 1H chemical shifts for the unmodiﬁed and Amadori modiﬁed peptide in PBS containing 30% (v/v) TFE at 10 C
Residue HN Ha Others
86 Ser 4.00 Hb1/b2 3.79/3.87
87 Asp 8.70 4.91 Hb1/b2 2.76/2.59
*Pro 4.37 Hb1 2.23, Hc1 1.94, Hd1 3.78
89 Thr 8.05 4.15 Hb1 4.04, Hc21 1.11
90 Ala 7.31 4.15 Hb1 1.35
91 Ser 7.97 4.24 Hb1/b2 3.87/3.78
92 Val 7.86 3.80 Hb1 2.01, Hc1l/c21 0.82/0.87
93 Asn 8.12 4.48 Hb1 2.70, Hd21/d22 7.46/6.76
94 Cys 7.99 4.18 Hb1/b2 2.88/2.86
95 Ala 8.03 3.97 Hb1 1.34
96 Lys 8.03 3.93 Hb1/b2 1.73/1.57, Hc1/c2 1.28/1.46, Hd11.56, He1 2.82
97 Lys 7.56 4.02 Hb1/b2 1.69/1.81, Hc1/c2 1.30/1.37, Hd1 1.56, Hel 2.86
98 Ile 7.87 3.53 Hb1 1.82, Hc1l/c21/c12 l.03/0.77/1.52, Hd1 0.72
99 Val 8.08 3.84 Hb1 2.00, Hy11/c21 0.82/0.87
100 Ser 7.99 4.28 Hb1 3.86
101 Asp 8.21 4.59 Hb1 2.81
102 Gly 8.16 3.85
103 Asn 8.07 4.63 Hb1 2.73, Hd21/d22 7.45/6.70
104 Gly 8.28 3.87/3.77
105 Met 7.78 4.31 Hb1/b2 1.87/2.02, Hc1/c2 2.35/2.42
Modiﬁed peptide
86 Ser 4.02 Hb1/b2 3.88/3.80
87 Asp 8.70 4.91 Hb1/b2 2.76/2.58
*Pro 4.39 Hb1/b2 2.24/l.93, Hc1 1.94, Hd1 3.81
89 Thr 8.13 4.16 Hb1 4.02, Hc1 1.12
90 Ala 7.86 4.15 Hb1 1.36
91 Ser 7.97 4.21 Hb1 3.78
92 Val 7.84 3.80 Hb1 2.00, Hc1l/c21 0.88/0.83
93 Asn 8.16 4.47 Hb1 4.92, Hd21/d22 5.89/5.43
94 Cys 8.15 4.43 Hb1/b2 3.02/3.06
95 Ala 8.07 4.00 Hb1 1.34
96 Lys 7.99 3.92 Hb1/b21.74/1.66, Hc1/c2 l.30/1.39, Hd1 1.57, Hel 2.85
97 Lys 7.86 4.20 Hb1/b2 2.19/1.75, Hc2 1.50, Hd1 2.00, Hel 2.75, Hı¨2 5.10,
Hj2 3.60, Hc2 3.70, Hl2/l3 3.30/3.40
98 Ile 7.97 3.83 Hb1 1.83, Hc11/c21/c121.01/0.77/1.25, Hd31 0.72
99 Val 8.10 3.84 Hb1 2.02, Hc11/c21 0.83/0.89
100 Ser 7.99 4.28 Hb1 3.82
101 Asp 8.22 4.58 Hb1 2.79
102 Gly 8.15 3.86
103 Asn 8.08 4.64 Hb1 2.75, Hd22/d21 6.72/7.47
104 Gly 8.30 3.87/3.78
105 Met 7.75 4.28 Hb1/b2 1.87/2.02, Hc1/c2 2.43/2.36
All chemical shifts are referenced externally to a 100 lM solution of dimethylsilapetane sulphonic acid (DSS) in PBS containing 30% (v/v) TFE. Key: *Ile88
in lysozymeﬁ Pro in model peptide.
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ed peptides. The number of contact types with additional
structural constraints are described in Tables 3 and 4 for
the lysozyme helix 4 and TIMP-2 AB b-hairpin peptides,
respectively. The distribution of restraints across each of
the peptides in both the unmodiﬁed and glycated forms is
depicted in Fig. 4. The NOE contact types observed in
the unmodiﬁed lysozyme helix 4 (Fig. 4A) support the pres-
ence of an a-helix conformation with NOEs observed
between Ha and HN (i–i + 3) as well as Ha and Hb (i–
i + 3). The NOE contact data in the glycated form of lyso-
zyme helix 4, however, showed disruption of the NOE pat-
tern consistent with a change in peptide conformation
relative to the unmodiﬁed. There was little change between
the NOE contact pattern of the unmodiﬁed and glycated
TIMP-2 AB b-hairpin peptide (Fig. 4B).
3.4. Structure calculations and analysis of the unmodiﬁed
and glycated lysozyme helix 4 peptides
All structural data were determined using CNS as
described in the experimental procedures. No calculated
structure gave violations greater than 0.2 A˚ or bond angle
violations greater than 5 from the restraint data when all
40 structures were used to compute the ensemble average
structural set. The rms deviation statistics for both the con-
trol and glycated lysozyme helix 4 peptides are shown in
Table 5. The unmodiﬁed ensemble (Fig. 5a) resulted in
good agreement between all calculated structures across
the entire peptide and direct comparison of the calculated
structure with the equivalent region in intact lysozyme
(pdb IE8L) showed excellent agreement between the two
structures (see Table 5). When the unmodiﬁed peptide
structure is represented as a ribbon diagram, the helical
nature of the peptide is observed (Fig. 5b). Energy compar-
isons between the models calculated here for the unmodi-
ﬁed and glycated peptides, and the same region in the
intact lysozyme structure, are shown in Table 6.
The rms deviation of the ensemble of the modiﬁed pep-
tide showed a relatively poor agreement across the entire
peptide, however each end of the structure showed much
better agreement with the deviation occurring between res-
idues 96–98 (Fig. 5c and Table 5). We note that the area of
relatively poor agreement in the glycated peptide ensemble
contains the modiﬁed Lys97 residue. When the calculated
structure is represented as a ribbon diagram, loss of the
helical nature of the peptide relative to the control is clearly
Table 2
TIMP-2 AB b-hairpin NMR assignment list of observed 1H chemical shifts for the unmodiﬁed and Amadori modiﬁed peptide in PBS at 0 C
Residue HN Ha Others
Cys 4.16 Hb1/b2 2.90/2.93
29 Val 8.58 4.01 Hb1 1.77, H c1l 0.65
30 Asp 8.53 4.48 Hb1/b2 2.39/2.54
31 Ser 8.18 4.25 H b1 3.53
32 Gly 8.16 3.54/3.87
33 Asn 8.30 5.08 Hb1/b2 2.09/2.30, Hd21/d22 7.24/6.52
34 Asp 8.80 4.30 Hb1/b2 2.41/3.03
35 He 7.79 3.68 Hb1 1.42, H c1l/c12 c21/ 0.37/0.59/0.35, Hd1 0.24
36 Tyr 7.68 4.28 Hb1/b2 2.66/3.02, Hd1/d1 6.51/6.81
37 Gly 7.88 3.30/3.95
38 Asn 8.20 4.84 Hb1/b2 2.42/2.61
39 Pro 4.50 Hb1/b2 1.72/2.00, Hc1 1.54, Hd1d1/ 3.45/3.62
40 Ile 8.17 3.74 Hb1 1.34, Hcll/c21/cl2 0.74/0.59/1.19, Hd1 0.50
41 Lys 8.36 4.21 Hb1/b2 1.39/1.48, Hcl/c2 1.06/1.12
42 Arg 8.43 4.23 Hb1 b1/ 1.47/1.60, Hc1 1.35, Hd1 2.90, Hel 6.99
Cys 8.31 4.21 Hb1/b2 2.70/2.95
Modiﬁed peptide
Cys 4.16 Hb1/b2 2.89/2.94
29 Val 8.58 4.00 Hb1 1.77, Hc11 0.64
30 Asp 8.58 4.51 Hb1/b2 2.45/2.60
31 Ser 8.19 4.23 Hb1 3.54
32 Gly 8.13 3.55/3.85
33 Asn 8.28 5.00 Hb1/b2 2.14/2.30, Hd21/d22 7.25/6.54
34 Asp 8.75 4.32 Hb1 b1/ 2.43/2.99
35 Ile 7.80 3.68 Hb1 1.42, Hc1l/c12 c21/ 0.39/0.59/0.35
36 Tyr 7.71 4.27 Hb1/b2 2.66/2.99, Hd1/d1 6.51/6.81
37Gly 7.89 3.30/3.92
38 Asn 8.15 4.82 Hb1/b2 2.44/2.58, Hd21/d22 6.94/6.80
39 Pro 4.48 Hb1/b2 1.72/2.00, Hc1 1.55, Hd1 d1/ 3.47/3.60
40 Ile 8.13 3.74 Hb1 1.36, H c1l/c21/c12 0.75/0.52/1.19, Hd1 0.58
41 Lys 8.31 4.20 Hb1/b2 1.37/1.49, Hc1/c2 1.06/1.11
42 Arg 8.29 4.22 Hb1 b1/ 1.47/1.60, Hc1 1.35, Hd12.90, Hel 6.98
Cys 8.24 4.23 Hb1/b2 2.72/2.95
All chemical shifts are referenced externally to a 100 lM solution of dimethylsilapetane sulphonic acid (DSS) in PBS.
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visible within the region 96–98 and the helix appears to
‘bend’ slightly (Fig. 5d). We note that not only did each
end of the modiﬁed peptide ensemble show good agree-
ment between the structures, each end of the modiﬁed
ensemble also matched the unmodiﬁed peptide ensemble
(Table 5).
PROCHECK-NMR analysis of the Ramachandaran
plot for the 40-structure ensemble of the control peptide
showed that 98.3% of all residues fell in either the most
favored or additionally allowed regions of the a-helix, with
the remaining 1.7% falling in the generously allowed
regions. Equivalent analysis of the glycated peptide showed
94.2% of all residues falling in the most favored or addi-
tionally allowed regions, with 4.8% falling into the gener-
ously allowed regions of the a-helix and the remaining
1% falling in disallowed regions.
3.5. Structure calculations and analysis of the TIMP-2 AB
b-hairpin peptides
All structural data were determined as described for the
lysozyme helix 4 peptide above. The rms deviation statistics
from 30 structures for both the unmodiﬁed and glycated
peptides are shown in Table 5. From the unmodiﬁed
ensemble (Figs. 6A) it was clear that the two ends of the
peptide showed a large amount of variation and this was
reﬂected in the rms deviations across the entire peptide
(Table 5). Removal of the two amino acids at each end
of the peptide from the calculations resulted in much better
agreement between all the calculated structures across the
entire peptide and direct comparison of this region of the
calculated structure with the equivalent region in intact
TIMP-2 (pdb 2TMP) showed agreement between the two
structures (see Table 5). Energy comparisons between the
models calculated here for the unmodiﬁed and glycated
peptides, and the same region in the intact TIMP-2 struc-
ture, are shown in Table 7.
The rms deviation of the ensemble of the modiﬁed pep-
tide (Fig. 6B) showed greater variation across the entire
peptide than the unmodiﬁed, although this once again
improved by removal of the two residues at either end
(Table 5). However, the structure of the peptide that had
been subjected to glycation conditions appears to be
unchanged compared to the control unmodiﬁed peptide
and the rms deviations from direct comparison of the
two conﬁrmed this (Table 5). Overlaying the ensembles
for both the control and modiﬁed peptides again showed
these to be more-or-less equivalent (Fig. 6C). Comparison
Fig. 1. Sugar box region of two-dimensional TOCSY NMR spectra for unmodiﬁed (A) and glycated (B) lysozyme helix 4 peptides and unmodiﬁed (C) and
glycated (D) TIMP-2 AB b-hairpin peptides. The outlined regions show the resonances from the sugar nuclei. All assignments are illustrated in the format:
[vertical (F1) ppm, horizontal (F2) ppm] and are for HN unless stated.
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of both the peptides together with the equivalent TIMP-2
AB turn region extracted directly from the TIMP-2
NMR structure (Muskett et al., 1998) conﬁrmed that the
structures were all very similar (Fig. 6D) as shown by the
rms deviation values (Table 5).
4. Discussion
The non-enzymatic reaction between reducing sugars
and protein amino groups (glycation), and the advanced
glycation end products (AGEs) derived from these glyca-
tion adducts, have now repeatedly been shown to cause
enzyme inactivation, protein aggregation, and precipitation
(Yeboah et al., 2004). Despite the importance of this pro-
tein modiﬁcation, the eﬀect(s) of glycation upon protein
structure remain largely unknown. Recently we have used
NMR to show that glycation of an HSA model peptide
results in conformational distortion of the secondary struc-
ture (Howard and Smales, 2005). Here, we have used NMR
to extend this investigation and describe the eﬀect of glyca-
tion on the secondary structure of other model peptides.
NMR analysis of the modiﬁed lysozyme helix 4 peptide
showed that glycation had indeed occurred and further,
that this had occurred preferentially on Lys97. This was
conﬁrmed by the lysine Ha chemical shift diﬀerences
between the unmodiﬁed and glycated peptides and investi-
gation of the chemical shifts for each of the protons within
the two lysine residues (Fig. 3). Preferential glycation of
Lys97 in the model peptide agrees with the intact protein
data where it has previously been shown that Lys97 is pref-
erentially glycated over Lys96 when modiﬁed under similar
conditions (Smales et al., 2000). In the case of the intact
protein, it is thought that preferential glycation occurs at
this residue due to the relative surface accessibilities of
the two NH2 amino groups and local acid-base catalysis
(Smales et al., 2000). Indeed, it has long been realized that
glycation is more likely to occur on lysine residues which
Fig. 2. Diﬀerence in 1H NMR chemical shift observed between each
residue in the unmodiﬁed and glycated peptides. (A) lysozyme helix 4, (B)
TIMP-2 AB b-hairpin.
Fig. 3. Diﬀerence in NMR chemical shift observed for each assigned
proton for the two lysine residues (Lys96 , Lys97 ) in lysozyme helix 4
between the unmodiﬁed and glycated peptides.
Table 3
NOE, hydrogen bond and torsion angle connectives for both unmodiﬁed








i–i + 2 4 3
i–i + 3 25 12
i–j (>3) 6 3
Total 210 176
Hydrogen bond donors 13 7
Torsion angles / 18 13
Table 4
NOE, hydrogen bond and torsion angle connectives for both unmodiﬁed
and glycated TIMP-2 AB b-hairpin peptide




i–i + 2 5 7
i–i + 3 1 0
i–j (>3) 25 27
Total 203 224
Hydrogen bond donors 0 0
Torsion angles / 8 6
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are close to other amino groups (Iberg and Flu¨ckiger,
1986). From our previous study using an HSA model pep-
tide, we predict that no secondary structure is present in
aqueous PBS solution in the absence of TFE (the condi-
tions under which glycation is performed) and therefore
while accessibility may explain the preferential glycation
in the intact protein, local acid-based catalysis must give
rise to the speciﬁcity in this case. Those amino acids neigh-
boring each of the lysine residues must result in Lys97 being
more nucleophilic than Lys96 and explaining its preferential
glycation. Glycation of Lys97 may in turn lead to steric hin-
drance of Lys96, limiting or preventing the formation of
diglycated adducts whereby Lys96 and Lys97 would both
be modiﬁed.
As in many peptide studies we utilized 2,2,2-triﬂuoroeth-
anol (TFE) in order to drive the formation of, and stabi-
lize, the lysozyme helix 4 model peptide as it is well
documented that many peptides do not have a propensity
to form helical secondary structure in the absence of such
agents (Howard and Smales, 2005). The control lysozyme
helix 4 peptide formed a typical a-helix in the presence of
30% (v/v) TFE that was consistent with the equivalent helix
in the intact protein (Fig. 5). On-the-other-hand, NMR
analysis of the glycated lysozyme helix 4 peptide in the
presence of 30% (v/v) TFE shows that the helical nature
of the peptide is severely disrupted immediately around
the site of modiﬁcation (Fig. 5). Further, the region around
the modiﬁcation showed a large amount of ﬂexibility in the
Fig. 4. Schematic of NOE contact types, hydrogen bond acceptors and
residues giving rise to / restraints for both the unmodiﬁed (A) and
glycated (B) lysozyme helix 4 peptides, and the unmodiﬁed (C) and
glycated (D) TIMP-2 AB b-hairpin peptides are shown. The width of the
lines indicates the relative strength of the observed NOEs as determined
from the number of contour lines. The backbone medium range NOEs
observed in the TIMP-2 AB b-hairpin unmodiﬁed (E) and modiﬁed (F)
peptides are also depicted.
Table 5
Summary of the rms deviation values for lysozyme helix 4 and TIMP-2
AB P b-hairpin
Peptide(s) Region rmsd
Lysozyme helix 440 structures 86–105 0.728
86–104 0.628








Lysozyme helix 4 peptide cf Helix from intact protein
40 + 1 structures
87–104 0.653





TIMP–2 P b-hairpin cf TIMP-2 P b-hairpin from
intact protein 30 + 1 structures
29–42 1.668












TIMP-2 P b-hairpin cf Amadori TIMP-2 P b-hairpin cf
TIMP-2 1 + 1 + 1 structures
29–42 1.330
30–41 1.073
Comparison of values for peptides before and after modiﬁcation are
shown together with comparisons to the equivalent region of the intact
protein.
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glycated peptide and did not adopt one ﬁxed conformation
(Fig. 5), suggesting that glycation of Lys97 not only dis-
rupts, but completely destroys, the interactions maintain-
ing the helix in this region. It is the loss of structural
NOE contacts that leads to this conclusion. Interestingly,
the remainder of the helical structure at each end of the
peptide remains unchanged upon glycation and it is only
in the immediate vicinity of the modiﬁcation that the helic-
ity of the peptide is compromised (Fig. 5). We therefore
suggest that glycation of Lys97 destroys the helical nature
of the peptide within this region due to an enthalpy eﬀect,
whereby the presence of the attached sugar moiety leads to
the disruption of the local non-covalent interactions stabi-
lizing the helix in this area. We note that CD analysis of the
control and glycated peptides in TFE also conﬁrmed the
presence of helical structure in both cases, and whilst there
was some change between the two spectra we were unable
to draw any further conclusions based upon this data as to
how or where the helical structure may have been disrupted
(data not shown).
The ﬁnding that glycation of the lysozyme helix 4 pep-
tide disrupts the helical nature of the peptide is consistent
with our previous ﬁndings using an HSA model helix form-
ing peptide (Howard and Smales, 2005). As mentioned
above, glycation of the lysozyme peptide leads to com-
pletely disordered structure in the region of the modiﬁed
lysine residue whilst the glycated HSA peptide maintained
ordered structure around the region of modiﬁcation. In the
glycated HSA peptide, NOE contacts between the protons
in the sugar moiety and the surrounding amino acid residue
protons were clearly observed, forcing and stabilizing the
distorted helical structure observed (Howard and Smales,
2005). In the current study, however, there are no observa-
ble NOE contacts between the attached sugar moiety and
the peptide, leaving the sugar relatively ﬂexible. Thus,
whilst modiﬁcation of the peptide disrupted the local sec-
ondary structure of the lysozyme peptide, the lack of inter-
actions between the sugar moiety and the peptide means
that no conformation is preferred. A similar eﬀect was
reported upon glycation of the C-terminal region of a-crys-
tallin protein (Blakytny et al., 1997) where no NOEs were
observed between the sugar moiety and the peptide. Bla-
kytny and colleagues showed that the exact sites and level
of glycation could be identiﬁed, but the sugar did not sta-
bilize a preferred structure in solution (Blakytny et al.,
1997).
Our studies, and that of Blakytny and colleagues show
that the local environment, in terms of amino acid
sequence, not only plays an important role in determining
Fig. 5. Superimposition of all backbone heavy atoms of the 40-structure ensembles calculated from NMR data for lysozyme helix 4 unmodiﬁed (A) and
ribbon diagram created in MOLMOL of the structure closest to the mean is shown for the unmodiﬁed (B). Superimposition of all backbone heavy atoms
of the 40-structure ensembles calculated from NMR data for glycated lysozyme helix 4 residues 86–101 ﬁtted over residues 86–95, and residues 95–105
ﬁtted over residues 99–105 (C). Ribbon diagram created in MOLMOL of the structure closest to the mean is shown for the glycated peptide (D). We stress
that ﬁgure (D) represents the structure closest to the mean and does not imply that the orientation of the two helical portions are actually constrained in
the manner shown.
Table 6
Average ensemble energies (kJ mol1) for calculated structures of both
unmodiﬁed and glycated lysozyme peptide obtained from DEEPVIEW
using GROMOS9643B1
Energy Unmodiﬁed Glycated Helix from Lysozyme
1E8L.pdb
Bonds 13.40 12.66 2.20
Angles 53.84 58.50 55.10
Torsions 135.29 157.39 140.60
Impropers 15.89 21.56 17.30
Nonbonded 325.60 267.43 272.50
Total (kJmol1) 107.18 17.32 38.30
Energies for the equivalent helix within lysozyme structure lE8L.pdb are
also shown for comparison.
Table 7
Average ensemble energies (kJmol1) for calculated structures of both
unmodiﬁed and glycated TIMP-2 peptide obtained from DEEPVIEW
using GROMOS9643B1
Energy Unmodiﬁed Glycated 2TMP.pdb
Bonds 12.90 17.60 12.70
Angles 41.20 69.00 50.00
Torsions 125.60 128.70 102.30
Impropers 14.70 14.40 16.50
Nonbonded 261.60 142.01 167.20
Total (kJ mol1) 67.20 87.69 14.3
Energies for the equivalent region within TIMP-2 structure 2TMP.pdb are
also shown for comparison.
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which lysine residue in a dilysine motif is glycated, but also
plays a key role in determining whether such a modiﬁcation
leads to ordered or disordered secondary structure. In the
absence of interactions between the sugar residue and the
peptide backbone the local structure will be disordered,
however, if nearby amino acids provide suitable partners
for interactions with the sugar moiety a preferred structure
will be adopted as in the case of the HSA model peptide.
We note that in the case of the intact protein additional,
interactions between the helix and the bulk protein that sta-
bilize the helix are likely to be important in terms of the
gross eﬀect of glycation upon the helix structure. It is also
interesting to note that previous studies have suggested that
glycation of human serum albumin can lead to conforma-
tion change (Shaklai et al., 1984), although to our knowl-
edge there have been no reports on the eﬀect of glycation
on lysozyme protein secondary and/or tertiary structure.
There was only a relatively weak ‘sugar box’ observed in
the TOCSY NMR spectra of the TIMP-2 AB b-hairpin
after modiﬁcation suggesting that very little glycation of
the peptide had taken place. There is only one lysine resi-
due in the TIMP-2 AB b-hairpin, which may explain the
relatively low reactivity of this residue compared to those
in dilysine motifs. Even if there was modiﬁcation, as the
lysine residue is towards the end of the peptide, any local
disruption in this area that is already less ordered may
not be apparent. These results suggest that either (a) the
single lysine residue within the peptide is relatively unreac-
tive and hence engineering dilysine motifs to single lysines
could be an approach to limit glycation, or (b) that glyca-
tion of lysine residues towards the termini of secondary
structures does not appreciably perturb the secondary
structure, although further work needs to be carried out
in other amino acid positions to conﬁrm this. We cannot
Fig. 6. Superimposition of all backbone heavy atoms of the 30-structure ensembles calculated from NMR data for unmodiﬁed TIMP-2 AB b-hairpin
peptide (A) and ‘‘modiﬁed’’ TIMP-2 b-hairpin peptide (B). Superimposition of all backbone heavy atoms of the 60-structure ensembles calculated from
NMR data for unmodiﬁed TIMP-2 b-hairpin peptide and ‘‘modiﬁed’’ peptide together (C). Superimposition of the structures closest to the mean for
unmodiﬁed TIMP-2 b-hairpin peptide (blue) and ‘‘modiﬁed’’ TIMP-2 b-hairpin (red) peptides and the equivalent region of intact TIMP-2 (green) (D).
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rule out the possibility that the disulﬁde bond in the hair-
pin, which is necessary to maintain the hairpin structure,
may prevent destabilization or structural perturbation
upon glycation of the peptide.
In summary we have shown that glycation of model heli-
cal peptides results in local disruption of secondary struc-
ture, and that the secondary structure adopted upon
glycation is dependent upon whether the attached sugar
moiety forms stable interactions with the peptide itself.
We also provide evidence that the resulting eﬀect of glyca-
tion upon structure is sequence speciﬁc and determined by
the local environment. These ﬁndings, and the structural
consequences, will allow us to interrogate the local environ-
ment in other peptides and proteins to predict the likeli-
hood of glycation, and then model the potential eﬀect
such modiﬁcation might have upon structure/function.
Such information will be useful in helping to develop bio-
therapeutic and food bioprocessing strategies that limit
such potentially damaging reactions and structural distor-
tions upon modiﬁcation to maintain protein integrity. Fur-
ther, in the case of recombinant biopharmaceuticals, it may
be possible to engineer the protein to remove potentially
reactive lysine resides without compromising the structure
and function of the target protein. Finally, the fact that gly-
cation can result in structural changes is likely to help
improve our understanding of disease pathologies involv-
ing aggregation (e.g. transmissible neurodegenerative dis-
eases) where glycation is known to occur (Choi et al.,
2004).
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